Amedeo's Top 20

Amedeo Smart

Independent Medical Education

20 May 2024

Multidisciplinary Journal Club

  1. Geraghty LE, Dunne EA, Ni Chathasaigh CM, Vellinga A, et al.
    Video versus Direct Laryngoscopy for Urgent Intubation of Newborn Infants.
    N Engl J Med 2024.

  1. Kuriyama K, Murakami K, Masuda T, Sugiura K, et al.
    Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial.
    Vaccine 2023.

  2. Costalat V, Jovin TG, Albucher JF, Cognard C, et al.
    Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size.
    N Engl J Med 2024;390:1677-1689.

  3. Fortea J, Pegueroles J, Alcolea D, Belbin O, et al.
    APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease.
    Nat Med 2024.

  4. Sant VR, Radhachandran A, Ivezic V, Lee DT, et al.
    From Bench-to-Bedside: How Artificial Intelligence Is Changing Thyroid Nodule Diagnostics.
    J Clin Endocrinol Metab 2024.

  1. Gokbuget N, Boissel N, Chiaretti S, Dombret H, et al.
    Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
    Blood 2024;143:1903-1930.

  2. Zaffaroni G, Mannucci A, Koskenvuo L, de Lacy B, et al.
    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis
    Br J Surg 2024;111.

  3. Sohn SY, Inoue K, Bashir MT, Currier JW, et al.
    Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis.
    J Clin Endocrinol Metab 2024.

  4. Petrillo S, Di Prinzio RR, Quatrana A, Santoro A, et al.
    Redox biomarkers in asymptomatic latent human tuberculosis: a comparison with active disease.
    J Infect Dis 2024.

  5. Gubbi S, Al-Jundi M, Foerster P, Cardenas S, et al.
    The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    Thyroid 2024.

  1. Chan GC, Kalantar-Zadeh K, Ng JK, Tian N, et al.
    Frailty in Patients on Dialysis.
    Kidney Int 2024.

  2. Bjornebo L, Razdan S, Discacciati A, Palsdottir T, et al.
    Prostate Cancer Incidence and Mortality in Men Exposed to alpha1-Adrenoceptor Antagonists.
    J Natl Cancer Inst 2024.

  3. Selten JP, Di Forti M, Quattrone D, Jones PB, et al.
    The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.
    Psychol Med 2024.

  4. Vo JB, Ramin C, Veiga LHS, Brandt C, et al.
    Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in U.S. breast cancer survivors.
    J Natl Cancer Inst 2024.

  5. Perucca P, Bourikas D, Voinescu PE, Vadlamudi L, et al.
    Lacosamide and pregnancy: Data from spontaneous and solicited reports.
    Epilepsia 2024;65:1275-1284.

  1. Aredo JV, Wakelee HA.
    Top advances of the year: Perioperative therapy for lung cancer.
    Cancer 2024.

  2. van der Wekken-Pas L, Weiss F, Simon-Zuber C, Sebisch R, et al.
    Cabotegravir and rilpivirine long acting injectables in a pregnant woman living with HIV.
    Clin Infect Dis 2024.

  3. Fallik N, Trakhtenbroit I, Fahoum F, Goldstein L, et al.
    Therapeutic drug monitoring in pregnancy: Levetiracetam.
    Epilepsia 2024;65:1285-1293.

  4. Bidulka P, Lugo-Palacios DG, Carroll O, O'Neill S, et al.
    Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
    BMJ 2024;385:e077097.

  5. Buse DC, Sakai F, Matharu M, Reed ML, et al.
    Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
    Headache 2024.


Privacy Policy